Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $30.83.
A number of equities analysts have recently issued reports on the company. Jefferies Financial Group downgraded Option Care Health from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Truist Financial lowered their target price on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Finally, The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th.
Read Our Latest Stock Analysis on OPCH
Option Care Health Trading Up 0.2 %
NASDAQ OPCH traded up $0.04 on Friday, hitting $23.80. The company's stock had a trading volume of 792,365 shares, compared to its average volume of 1,549,915. The firm has a market cap of $4.05 billion, a PE ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32. The company's 50-day moving average is $26.84 and its 200 day moving average is $28.89. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63.
Insider Activity at Option Care Health
In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Option Care Health
A number of hedge funds have recently added to or reduced their stakes in OPCH. Wellington Management Group LLP lifted its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. FMR LLC raised its holdings in shares of Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP lifted its position in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after acquiring an additional 599,589 shares in the last quarter. State Street Corp boosted its stake in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company's stock valued at $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after purchasing an additional 404,811 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Company Profile
(
Get Free ReportOption Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.